Figma Shares Indicated To Open $105/$110
Investing.com - Biogen reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Biogen announced earnings per share of $5.34 on revenue of $2.69B. Analysts polled by Investing.com EPS of $5.02 on revenue of $2.66B.
Biogen 's are up 10% and is trading at $269.85 , still down 25.85% from its 52 week high of $363.92 set on Wednesday, November 4, 2020.
Biogen follows other major Healthcare sector earnings this month
Biogen's report follows an earnings beat by J&J on Tuesday, who reported EPS of $2.59 on revenue of $22.32B, EPS of $2.33 on revenue of $22.01B.
Abbott Labs had beat expectations on Tuesday with first quarter EPS of $1.32 on revenue of $10.46B, for EPS of $1.27 on revenue of $10.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar